147 related articles for article (PubMed ID: 8138571)
1. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
Bayly AC; Roberts RA; Dive C
J Cell Biol; 1994 Apr; 125(1):197-203. PubMed ID: 8138571
[TBL] [Abstract][Full Text] [Related]
2. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
3. Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis.
Bayly AC; French NJ; Dive C; Roberts RA
J Cell Sci; 1993 Feb; 104 ( Pt 2)():307-15. PubMed ID: 8389374
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
Strange J; Roberts RA
Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
[TBL] [Abstract][Full Text] [Related]
5. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas.
Gill JH; James NH; Roberts RA; Dive C
Carcinogenesis; 1998 Feb; 19(2):299-304. PubMed ID: 9498280
[TBL] [Abstract][Full Text] [Related]
6. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
Hasmall SC; West DA; Olsen K; Roberts RA
Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
Hasmall SC; James NH; Soames AR; Roberts RA
Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
[TBL] [Abstract][Full Text] [Related]
9. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
Gill JH; Brickell P; Dive C; Roberts RA
Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
[TBL] [Abstract][Full Text] [Related]
10. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
[TBL] [Abstract][Full Text] [Related]
11. Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1.
Oberhammer FA; Qin HM
Carcinogenesis; 1995 Jun; 16(6):1363-71. PubMed ID: 7788856
[TBL] [Abstract][Full Text] [Related]
12. Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator.
Bieri F; Bentley P; Waechter F; Stäubli W
Carcinogenesis; 1984 Aug; 5(8):1033-9. PubMed ID: 6146407
[TBL] [Abstract][Full Text] [Related]
13. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis.
Elcock FJ; Chipman JK; Roberts RA
Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883
[TBL] [Abstract][Full Text] [Related]
14. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA
Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472
[TBL] [Abstract][Full Text] [Related]
15. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
Roberts RA; Soames AR; Gill JH; James NH; Wheeldon EB
Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
[TBL] [Abstract][Full Text] [Related]
17. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
Hasmall S; James N; Hedley K; Olsen K; Roberts R
Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?
Rolfe M; James NH; Roberts RA
Carcinogenesis; 1997 Nov; 18(11):2277-80. PubMed ID: 9395232
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.
Chevalier S; Macdonald N; Tonge R; Rayner S; Rowlinson R; Shaw J; Young J; Davison M; Roberts RA
Eur J Biochem; 2000 Aug; 267(15):4624-34. PubMed ID: 10903494
[TBL] [Abstract][Full Text] [Related]
20. Role of MAP kinase signalling pathways in the mode of action of peroxisome proliferators.
Cosulich S; James N; Roberts R
Carcinogenesis; 2000 Apr; 21(4):579-84. PubMed ID: 10753189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
